Trial
NCT00540839
A Study of Montelukast (MK-0476) Compared With Fluticasone in Pediatric Participants With Chronic Asthma (MK-0476-303)
Phase IIIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Organon and Co
Collaborators
—
Condition
Asthma, Bronchial
Intervention
Montelukast sodium
Why stopped
Based on input from regulatory agencies, it is not necessary to conduct this study. An ongoing study was sufficient for regulatory purposes.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-02-14